Accelerated Antibody Discovery Targeting the SARS_CoV-2 Spike Protein for COVID-19 Therapeutic Potential

View the Webinar

Presented by

Colby Souders

Abveris

RECORDED AT Writing the Future of Infectious Disease

Covered in this Webinar

Two parallel, yet distinct, in vivo approaches for accelerated discovery of antibodies targeting the SARS-CoV-2 spike protein.

A single B-cell discovery workflow to directly interrogate antibodies secreted from plasma cells for binding specificity and ACE2.

A concurrent accelerated hybridoma-based workflow utilizing a DiversimAb™ mouse model for increased diversity.

Rapid deployment of technologies capable of high-throughput and high-resolution screening is imperative for timely response to viral outbreaks. Risk mitigation in the form of leveraging multiple advanced technologies further increases the likelihood of identifying efficacious treatments in aggressive timelines.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Accelerated Antibody Discovery Targeting the SARS_CoV-2 Spike Protein for COVID-19 Therapeutic Potential

Related Resources

Improved GPCR Engineering with Synthetic Site Saturation Variant Libraries

Enhancing Therapeutic Properties of a Cancer-Targeting Affibody by Soft Mutagenesis CVL Libraries

Accelerate Your Discovery Efforts with Twist Antibody Libraries